Mycophenolate mofetil and Procysbi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mycophenolate mofetil (mycophenolate mofetil) and Procysbi (cysteamine bitartrate). Common drug interactions include gingivitis ulcerative among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Mycophenolate mofetil and Procysbi. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Procysbi?

Procysbi has active ingredients of cysteamine bitartrate. eHealthMe is studying from 998 Procysbi users. Check the latest studies of Procysbi.

On Jul, 13, 2026

29 people who take Mycophenolate mofetil and Procysbi together, and have interactions are studied.

Mycophenolate mofetil and Procysbi drug interactions.

What are the common drug interactions of Mycophenolate Mofetil and Procysbi, by gender? *:

female:

Gingivitis ulcerative (infection of gums with ulcers)
Leukopenia (less number of white blood cells in blood)
Nausea (feeling of having an urge to vomit)
Abdominal discomfort
Hypersensitivity
Migraine (headache)
Abdominal pain upper
Cystitis (inflammation of the wall of the bladder)
Headache (pain in head)
Kidney transplant rejection

male:

Nausea (feeling of having an urge to vomit)
Dyspepsia (indigestion)
Neutropenia (an abnormally low number of neutrophils)
Oropharyngeal pain
Transplant rejection (a transplant material is not worked)
Diarrhoea
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Graft complication
Histoplasmosis (infection caused by breathing in spores of a fungus)
Pyrexia (fever)

What are the common drug interactions of Mycophenolate Mofetil and Procysbi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Hypersensitivity

10-19:

Graft complication
Histoplasmosis (infection caused by breathing in spores of a fungus)
Pyrexia (fever)
Neutropenia (an abnormally low number of neutrophils)
Transplant rejection (a transplant material is not worked)

20-29:

Gingivitis ulcerative (infection of gums with ulcers)
Leukopenia (less number of white blood cells in blood)
Abdominal discomfort
Kidney transplant rejection
Migraine (headache)
Nausea (feeling of having an urge to vomit)

30-39:

Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Cystinosis (abnormal accumulation of the amino acid cystine): 18 people, 62.07%
Amino Acid Metabolism Disorder: 4 people, 13.79%
Immunodeficiency Disorders: 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and Procysbi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously